Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study. [electronic resource]
Producer: 20170714Description: 253-260.e1 p. digitalISSN:- 1556-5653
- Adamantane -- administration & dosage
- Adiposity -- drug effects
- Adolescent
- Adult
- Androgens -- blood
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Delayed-Action Preparations
- Dipeptides -- administration & dosage
- Dipeptidyl-Peptidase IV Inhibitors -- administration & dosage
- Drug Administration Schedule
- Drug Combinations
- Female
- Glucose Tolerance Test
- Humans
- Hypoglycemic Agents -- administration & dosage
- Insulin -- blood
- Menstrual Cycle -- drug effects
- Metformin -- administration & dosage
- Pilot Projects
- Polycystic Ovary Syndrome -- blood
- Prediabetic State -- blood
- Single-Blind Method
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.